They stirred public outrage after it became clear that some members of Congress had been briefed on the economic and health threat the virus posed.
There is no evidence that Perdue, who is among the wealthier members of the Senate, acted on information gained as a member of Congress or through his long-standing relationship with company officials.But legal experts say the timing of his sale, the fact that he quickly bought Cardlytics stock back when it had lost two-thirds of its market value and his close ties to company officials all warrant scrutiny.The Perdue campaign declined a request for an interview with the senator.In a statement, Perdue spokesperson John Burke said the senator had been cleared of wrongdoing but did not provide details.
“The bi-partisan Senate Ethics Committee, DOJ and SEC all independently and swiftly cleared Senator Perdue months ago, which was reported on,†Burke said.She said one way for members of Congress to avoid questions about their financial holdings is to put them in a blind trust, which Perdue has not done.
“All of these questions about the motivations behind our members of Congress and their personal securities trading could be alleviated if Congress passed a law that limited investments,†said Nagy, who specializes in securities law.The issue was enough of a liability that Perdue abruptly sold off between $3.2 million and $9.4 million of his stock portfolio over a four-day period in mid-April, according to an Associated Press review of mandatory financial disclosures he has submitted to the Senate.